Literature DB >> 24960064

Serum proteomic analysis reveals potential serum biomarkers for occupational medicamentosa-like dermatitis caused by trichloroethylene.

Peiwu Huang1, Xiaohu Ren2, Zhijun Huang3, Xifei Yang2, Wenxu Hong2, Yanfang Zhang4, Hang Zhang1, Wei Liu2, Haiyan Huang2, Xinfeng Huang2, Desheng Wu2, Linqing Yang2, Haiyan Tang4, Li Zhou2, Xuan Li2, Jianjun Liu5.   

Abstract

Trichloroethylene (TCE) is an industrial solvent with widespread occupational exposure and also a major environmental contaminant. Occupational medicamentosa-like dermatitis induced by trichloroethylene (OMLDT) is an autoimmune disease and it has become one major hazard in China. In this study, sera from 3 healthy controls and 3 OMLDT patients at different disease stages were used for a screening study by 2D-DIGE and MALDI-TOF-MS/MS. Eight proteins including transthyretin (TTR), retinol binding protein 4 (RBP4), haptoglobin, clusterin, serum amyloid A protein (SAA), apolipoprotein A-I, apolipoprotein C-III and apolipoprotein C-II were found to be significantly altered among the healthy, acute-stage, healing-stage and healed-stage groups. Specifically, the altered expression of TTR, RBP4 and haptoglobin were further validated by Western blot analysis and ELISA. Our data not only suggested that TTR, RBP4 and haptoglobin could serve as potential serum biomarkers of OMLDT, but also indicated that measurement of TTR, RBP4 and haptoglobin or their combination could help aid in the diagnosis, monitoring the progression and therapy of the disease.
Copyright © 2014. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  2D-DIGE; MALDI-TOF-MS/MS; Occupational medicamentosa-like dermatitis induced by trichloroethylene (OMLDT); Serum biomarkers

Mesh:

Substances:

Year:  2014        PMID: 24960064     DOI: 10.1016/j.toxlet.2014.05.024

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  1 in total

1.  Quantitative Proteomic Profiling of Tachyplesin I Targets in U251 Gliomaspheres.

Authors:  Xuan Li; Jianguo Dai; Yongjun Tang; Lulu Li; Gang Jin
Journal:  Mar Drugs       Date:  2017-01-18       Impact factor: 5.118

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.